Free Trial
CNSX:PLUS

ePlus (PLUS) Stock Price, News & Analysis

About ePlus Stock (CNSX:PLUS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$62.02
$74.01
52-Week Range
N/A
Volume
20,900 shs
Average Volume
193,039 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PLUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ePlus and its competitors with MarketBeat's FREE daily newsletter.

PLUS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

PLUS Stock Analysis - Frequently Asked Questions

Shares of PLUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ePlus investors own include Curaleaf (CURLF), Allena Pharmaceuticals (ALNA), Aphria (APHA), Ampliphi Biosciences (APHB), Actinium Pharmaceuticals (ATNM), Green Organic Dutchman (TGOD) and Arbutus Biopharma (ABUS).

Industry, Sector and Symbol

Stock Exchange
CNSX
Sector
Medical
Industry
Pharmaceuticals - Other
Sub-Industry
N/A
Current Symbol
CNSX:PLUS
CIK
1022408
Fax
N/A
Employees
1,560
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (CNSX:PLUS) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners